Jean-Marc Bellemin was appointed as Chief Financial Officer of Iovance Biotherapeutics on December 14, 2020. Based in San Carlos, United States.
Jean-Marc Bellemin was appointed as Chief Financial Officer of Iovance Biotherapeutics on December 14, 2020. He brings 27 years of experience in finance, including roles at public companies like Gritstone Oncology and Actelion Pharmaceuticals. His expertise aligns with Iovance's goals, particularly in global finance and commercial operations as the company transitions its TIL therapy to a commercial setting.
Full founder directory · Investor directory · Company funding database · Fundraising library